Joseph F. Rutledge
Profile
Joseph F.
Rutledge held several technology-related positions in various companies, including Director of Information Technology at Kainos Medicine, Chief Information Officer at Trimeris, and Chief Information Officer & VP-IT at Chimerix.
He also served as Vice President of Technology at iEntertainment Network, Practicing Smarter, and Chief Technology Officer at Vios.
Rutledge obtained his undergraduate degree from the University of Pittsburgh.
Former positions of Joseph F. Rutledge
| Companies | Position | End |
|---|---|---|
| Vios, Inc. | Chief Tech/Sci/R&D Officer | - |
| Practicing Smarter | Chief Tech/Sci/R&D Officer | - |
| IENTERTAINMENT NETWORK, INC. | Chief Tech/Sci/R&D Officer | - |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Chief Tech/Sci/R&D Officer | - |
Kainos Medicine, Inc. /old/
 Kainos Medicine, Inc. /old/ BiotechnologyHealth Technology Kainos Medicine, Inc. specializes in the research and development of innovative medicines for brain diseases, cancers, and infectious disease. The company was founded by Ki-Sub Lee and Myung-Cheol Kang on June 15, 2007 and is headquartered in Seongnam-si, South Korea. | Chief Tech/Sci/R&D Officer | - |
Training of Joseph F. Rutledge
| University of Pittsburgh | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 2 |
|---|---|
| IENTERTAINMENT NETWORK, INC. | Consumer Durables |
| CHIMERIX, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
| Vios, Inc. | |
Kainos Medicine, Inc. /old/
Kainos Medicine, Inc. /old/ BiotechnologyHealth Technology Kainos Medicine, Inc. specializes in the research and development of innovative medicines for brain diseases, cancers, and infectious disease. The company was founded by Ki-Sub Lee and Myung-Cheol Kang on June 15, 2007 and is headquartered in Seongnam-si, South Korea. | Health Technology |
| Practicing Smarter |
- Stock Market
- Insiders
- Joseph F. Rutledge
